Agilent Technologies Inc (NYSE:A) saw unusually large options trading on Monday. Stock investors bought 77,934 put options on the company. This represents an increase of approximately 1,169% compared to the average volume of 6,142 put options.
In other news, CEO Michael R. Mcmullen sold 21,850 shares of the business’s stock in a transaction dated Monday, January 29th. The stock was sold at an average price of $75.00, for a total transaction of $1,638,750.00. Following the sale, the chief executive officer now directly owns 324,687 shares in the company, valued at $24,351,525. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Michael R. Mcmullen sold 22,481 shares of the business’s stock in a transaction dated Friday, November 17th. The stock was sold at an average price of $68.77, for a total value of $1,546,018.37. Following the sale, the chief executive officer now owns 336,637 shares in the company, valued at $23,150,526.49. The disclosure for this sale can be found here. Insiders sold 219,991 shares of company stock worth $15,468,795 in the last 90 days.
A number of institutional investors have recently made changes to their positions in A. Dupont Capital Management Corp bought a new stake in Agilent Technologies during the third quarter worth $101,000. Front Row Advisors LLC bought a new position in Agilent Technologies in the 4th quarter valued at $106,000. AMG National Trust Bank bought a new position in Agilent Technologies in the 4th quarter valued at $201,000. Premia Global Advisors LLC bought a new position in Agilent Technologies in the 4th quarter valued at $204,000. Finally, Prudential PLC bought a new position in Agilent Technologies in the 2nd quarter valued at $211,000.
Agilent Technologies (NYSE:A) last released its quarterly earnings data on Monday, November 20th. The medical research company reported $0.67 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.62 by $0.05. The firm had revenue of $1.19 billion during the quarter, compared to the consensus estimate of $1.17 billion. Agilent Technologies had a return on equity of 16.95% and a net margin of 15.30%. The company’s quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.59 earnings per share. equities research analysts expect that Agilent Technologies will post 2.58 EPS for the current fiscal year.
A has been the topic of a number of recent analyst reports. Morgan Stanley reaffirmed an “overweight” rating on shares of Agilent Technologies in a research note on Tuesday, November 14th. Zacks Investment Research lowered Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Thursday, November 16th. ValuEngine lowered Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Friday, December 1st. Robert W. Baird reaffirmed a “buy” rating and issued a $72.00 price objective on shares of Agilent Technologies in a research note on Friday, November 24th. Finally, Barclays lifted their price objective on Agilent Technologies from $67.00 to $71.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 21st. Six analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Agilent Technologies presently has an average rating of “Buy” and a consensus price target of $69.25.
COPYRIGHT VIOLATION WARNING: This piece was reported by American Banking News and is the property of of American Banking News. If you are reading this piece on another domain, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this piece can be read at https://www.americanbankingnews.com/2018/02/14/agilent-technologies-sees-unusually-high-options-volume-a.html.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.